Trial intelligence / Profile preview

BMACCP: Autologous Bone Marrow MNCs for Cerebral Palsy

NCT01834664Phase 2Unknown

Sponsor
Chaitanya Hospital
Start
Mar 2013
Primary completion
Jun 2016
Countries
1
01

Overview

A Phase 2 trial of autologous bone marrow-derived mononuclear cell in cerebral palsy (CP), sponsored by Chaitanya Hospital. Status: unknown.

02

Drugs

autologous bone marrow-derived mononuclear cell
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on NCT01834664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01834664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call